Retatrutide Dosage Calculator: Complete Dosing & Reconstitution Guide
Master retatrutide dosing calculations, Phase 2 titration schedules, and peptide reconstitution math. Learn how to accurately calculate your doses and understand syringe conversions.
Understanding Retatrutide Dosing Tiers
Retatrutide dosing follows a structured Phase 2 titration protocol with four primary dose tiers. These tiers are designed to allow your body to adjust to the peptide while maximizing efficacy. The standard protocol escalates weekly doses from 1mg up to the 12mg maintenance dose over approximately 12 weeks.
Each dose tier serves a specific purpose: the 1mg starting dose establishes tolerance, the 4mg dose begins meaningful metabolic effects, the 8mg dose enhances weight loss signaling, and the 12mg maintenance dose represents the target therapeutic level used in Phase 2 trials that achieved 24.2% body weight loss at 48 weeks.
Phase 2 Standard Dosing Tiers
| Dose Tier | Duration | Weeks | Purpose |
|---|---|---|---|
| 1mg | Weekly injection | 1-4 | Tolerability, baseline GI adaptation |
| 4mg | Weekly injection | 5-8 | Initial metabolic effect, appetite suppression onset |
| 8mg | Weekly injection | 9-12 | Enhanced weight loss, GLP-1+GIP+glucagon signaling |
| 12mg | Weekly injection | 13+ | Maintenance dose, sustained weight loss and metabolic benefit |
Reconstitution Math for Compounded Peptides
Reconstitution is the process of mixing a lyophilized (freeze-dried) peptide powder with bacteriostatic water (BAC water) to create an injectable solution. Accurate reconstitution ensures consistent dosing across all your injections.
The fundamental equation is: Final Concentration (mg/mL) = Total Peptide Amount (mg) ÷ Total Volume (mL)
Standard Reconstitution Scenarios
The most common retatrutide vials are 10mg in 2mL BAC water. Here\'s how to calculate:
- 10mg vial + 2mL BAC water: 10mg ÷ 2mL = 5mg/mL concentration
- 5mg vial + 1mL BAC water: 5mg ÷ 1mL = 5mg/mL concentration
- 15mg vial + 3mL BAC water: 15mg ÷ 3mL = 5mg/mL concentration
Most compounders standardize to 5mg/mL, but always verify the concentration printed on your vial label. Never assume reconstitution; always verify with the pharmacy label or your provider.
Calculating Doses from Your Reconstitution
Once you know your concentration, calculate individual doses using: Syringe Volume (mL) = Desired Dose (mg) ÷ Concentration (mg/mL)
Example: You need 4mg and your concentration is 5mg/mL
- Syringe Volume = 4mg ÷ 5mg/mL = 0.8mL
- On a 1mL syringe, draw to the 0.8mL mark
Syringe Unit Conversions
Injectable medications use two common syringe measurement systems: volume-based (mL) and unit-based (U). Understanding the conversion prevents dangerous dosing errors.
Standard Syringe Markings
| Syringe Type | Unit Value | Conversion | Use Cases |
|---|---|---|---|
| 100-unit insulin syringe | 1 unit = 0.01mL | 100U = 1mL total | Most common for peptides, accurate to ±0.01mL |
| 40-unit insulin syringe | 1 unit = 0.025mL | 40U = 1mL total | Older style, less common for peptides |
| 1mL tuberculin syringe | Direct mL marks | 1mL = 1mL total | Larger volumes, less precise for peptides |
Converting Between Syringe Types
If your reconstitution calls for 0.8mL and you only have a 40-unit syringe, convert using the unit value:
- 0.8mL × (100 units / 1mL) = 80 units on a 100-unit syringe
- 0.8mL × (40 units / 1mL) = 32 units on a 40-unit syringe
Always use 100-unit insulin syringes when possible, as they provide superior precision for peptide dosing and are the standard recommended in clinical protocols.
Weight-Based vs Fixed Dosing
Two primary dosing strategies exist for retatrutide: weight-based dosing (adjusted by body weight) and fixed dosing (same dose for all patients). Understanding the difference helps you follow your provider\'s protocol correctly.
Fixed Dosing (Standard for Retatrutide)
Fixed dosing uses the same dose progression (1mg → 4mg → 8mg → 12mg) regardless of body weight. This is the approach used in Phase 2 trials and is the current standard for retatrutide. All participants escalated to the same maintenance dose of 12mg weekly, regardless of whether they weighed 150 lbs or 300 lbs.
Advantages of fixed dosing: Simplified protocol, consistent with clinical trial data, easier to implement in compounded settings.
Weight-Based Dosing
Weight-based dosing adjusts the dose based on body weight, typically expressed as mg/kg (milligrams per kilogram). For example, a dose might be 0.1mg per kilogram of body weight.
Example calculation: A 200-pound (90.9kg) patient at 0.1mg/kg would receive approximately 9.1mg per dose.
Weight-based dosing is less common for retatrutide but may be considered in special populations. Always follow your provider\'s specific recommendation, as they\'ll choose the protocol that works best for your individual situation.
Titration Schedule & Injection Timing
The titration schedule maps out exactly when to escalate doses and provides guidance on injection timing and spacing. Most providers recommend consistent weekly injection timing (e.g., every Monday at the same time) to maintain stable blood levels.
12-Week Standard Titration Timeline
| Time Period | Dose | Total Injections | Key Expectations |
|---|---|---|---|
| Weeks 1-4 | 1mg weekly | 4 injections | Mild nausea (1-2 days post-injection), mild appetite reduction |
| Weeks 5-8 | 4mg weekly | 4 injections | Moderate appetite suppression, GI effects peak, noticeable satiety |
| Weeks 9-12 | 8mg weekly | 4 injections | Strong appetite suppression, significant weight loss begins, GI adaptation improves |
| Week 13+ | 12mg weekly | Ongoing | Maximal appetite suppression, sustained weight loss, metabolic optimization |
Injection Day Best Practices
- Consistency: Inject on the same day and time each week (e.g., every Monday 8am)
- Rotation: Alternate injection sites (abdomen, thigh, upper arm) to prevent lipohypertrophy
- Timing: Inject before a meal to maximize appetite suppression effects
- Temperature: Store peptides at 2-8°C (refrigerator), allow to reach room temperature 15 minutes before injection
- Documentation: Track injection date, dose, site, and any side effects to share with your provider
When to Hold or Delay Escalation
Not everyone advances on the standard 4-week escalation schedule. Your provider may recommend holding at a lower dose or delaying escalation if you experience significant side effects. Understanding when to hold doses prevents adverse events and improves long-term adherence.
Common Reasons to Delay Escalation
- Severe nausea: If nausea is limiting food intake or quality of life, hold 1-2 weeks before escalating
- Persistent vomiting: Contact your provider immediately; this may indicate a need for medication support
- Constipation: Severe constipation may require stool softeners or laxatives before escalating
- Diarrhea: Conversely, severe diarrhea may need GI support; hold escalation until stabilized
- Abdominal pain: Persistent pain warrants provider evaluation before dose increases
- Rapid heart rate or palpitations: Always contact your provider before continuing
Dose Hold Protocol
If your provider recommends holding at your current dose, continue weekly injections at the same dose rather than stopping entirely. For example, if you\'re holding at 4mg instead of escalating to 8mg, continue 4mg weekly for 1-2 additional weeks, then reintroduce escalation if side effects resolve. Always follow your provider\'s specific instructions.
Common Reconstitution Errors to Avoid
Mistakes in reconstitution compound across all your doses, potentially causing under- or over-dosing throughout your entire protocol. Understanding common errors prevents these critical mistakes.
Top Reconstitution Mistakes
- Using non-sterile water: Always use bacteriostatic (BAC) water, never regular distilled water or saline
- Over-agitating the vial: Gentle rolling or rotation only; vigorous shaking denatures peptides
- Incorrect concentration calculation: Double-check your math; a 10mg/2mL vial is 5mg/mL, not 10mg/mL
- Failing to verify the vial label: Always read what the pharmacy labeled the vial as; don\'t assume
- Contaminated syringes or needles: Use sterile needles for every dose; never reuse needles between doses
- Temperature extremes: Don\'t freeze reconstituted solutions; keep refrigerated at 2-8°C
Dosage Calculator Tools & Resources
While manual calculations are essential to understand your dosing, several online tools can verify your math. However, always validate calculator results against your vial label and your provider\'s instructions, as errors in calculator design can propagate incorrect doses.
For additional guidance on dosing protocols, see our comprehensive guides on retatrutide dosing basics, the week-by-week dosing schedule, and general peptide dose calculations. If you\'re new to peptide reconstitution, read our guide on how to properly reconstitute peptides.
Frequently Asked Questions
The standard Phase 2 dosing starts at 1mg weekly for weeks 1-4, then escalates to 4mg, 8mg, and finally 12mg maintenance. Use this timeline: weeks 1-4 (1mg), weeks 5-8 (4mg), weeks 9-12 (8mg), week 13+ (12mg). Always follow your provider's specific protocol.
Divide the peptide amount by the final volume: 10mg ÷ 2mL = 5mg/mL final concentration. This means each 0.2mL syringe tick equals 1mg of retatrutide. For 4mg, you'd draw 0.8mL (4 × 0.2mL).
Unit syringes (40U or 100U) measure volume differently. A 40-unit syringe has 0.01mL per unit, while 100-unit has 0.01mL per unit (both 1 unit = 0.01mL). If your peptide is 5mg/mL, then 50 units on either syringe = 0.5mL = 2.5mg. Always confirm your syringe markings with your provider.
Most clinical trials use fixed dosing (1mg, 4mg, 8mg, 12mg) regardless of body weight, which is the recommended approach. Weight-based dosing (e.g., 0.1mg/kg) may be considered for special populations, but fixed dosing is standard for retatrutide. Consult your provider about which is appropriate for your situation.
Yes, dose adjustments are common during titration. If you experience significant nausea or GI upset at 4mg, your provider may recommend staying at 1mg longer or skipping a dose before escalating. Never skip doses without provider approval.
Always recalculate based on the actual volume provided. If you received a 10mg vial in 1mL instead of 2mL, your concentration is 10mg/mL (not 5mg/mL). Verify the vial label, calculate the new concentration, and adjust your syringe marks accordingly. Contact your provider if the volume seems incorrect.
Aim for precision within ±0.1mL when reconstituting. Use a sterile needle and syringe, ensure all powder dissolves fully, and keep the vial upright when withdrawing. Even slight variations compound across multiple doses, so consistency is key.